P783: SYSTEMIC THERAPY UTILIZATION AND HEMATOLOGIC OUTCOMES IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS): FINDINGS FROM A REAL-WORLD MEDICAL RECORD REVIEW STUDY IN THE US, UK,... by M. Diez-Campelo, A. Yucel, R. Goyal, R. C. Parikh, S. Dhuliawala, M. Jimenez, M. Sluga-O’Callaghan, C. Hughes, D. Tang, U. Germing

Get full text

P728: GENE EXPRESSION PROFILE REVELS T-LYMPHOCYTES ACTIVATION THROUGH CELL CYCLE PROGRESSION AND MITOCHONDRIAL METABOLISM REGULATION IN MYELODYSPLASTIC SYNDROMES WITH DEL(5Q) AFTER... by M. del Rey, L. A. Corchete, T. González, F. López-Cadenas, E. Lumbreras, S. M. Toribio, B. Xicoy, J. Sánchez-García, T. Bernal, G. F. Sanz, P. Fenaux, J. M. Hernández-Rivas, M. Diez-Campelo

Get full text

P788: FACTORS DRIVING TREATMENT DECISION IN PATIENTS WITH INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROME (MDS): A RETROSPECTIVE ANALYSIS FROM THE GRUPO ESPAÑOL DE SÍNDROMES MIELODISPLÁ... by M. Díez-Campelo, L. Hernandez-Donoso, E. Sasse, S. Colicino, J. Curto, A. Molero Yordi, M. Tormo Díaz, M. Arnan, G. Sanz, M. Díaz-Beyá, M. T. Cedena Romero, A. Jerez, D. Valcárcel Ferreiras

Get full text

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT... by A. DeZern, G. Marconi, D. Deeren, M. Diez Campelo, M. Lübbert, P. Krishnamurthy, Z. Nagy, G. Basak, A. Jonášová, E. Morozova, K. Geissler, Y. Ofran, H. Kelley, A. Volkert, K. Baker, Q. Kang-Fortner, G. Hodgson, C. Madigan, D. A. Roth, M. Kelly, P. Fenaux

Get full text

P756: ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) OVERLAP SYNDROMES. A SINGLE CENTER EXPERIENCE AND DISSECTION OF MUTATIO... by A. Avendaño Pita, M. Martín Izquierdo, S. Muntión Olave, T. Jímenez Solas, M. García Antúnez, L. Eva, M. Del Rey, S. Toribio Castelló, A. Yeguas Bermejo, T. González, J. M. Hernández-Rivas, A. Á. Martín López, M. Cabrero, E. Pérez López, A. Cabero, M. Baile, L. Vázquez, L. López Corral, F. Sánchez-Guijo, D. Caballero Barrigon, M. Cortés Rodríguez, M. Díez Campelo

Get full text

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion by Martín I. Castillo, Villamón E. Ribate, Calabuig M. Muñoz, Sanz G. Santillana, Such E. Taboada, Mora E. Casterá, Calasanz M. J. Abinzano, Irigoyen A. Barranco, Collado R. Nieto, Vara M. Pampliega, M. L. Blanco, Álvarez S. deAndrés, Pérez J. deOteyza, Bernal T. delCastillo, Granada I. Font, Jerez A. Cayuela, M. Díez‐Campelo, Abellán R. Sánchez, Solano C. Vercet, Tormo M. Díaz, Grupo Español de Síndromes Mielodisplásicos (GESMD)

Get full text